Finding Health Online
News for:   
 

   
 

For this drug, our server compiled this detailed Chemical Profile.

You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.

 

 
 
 
 

 

Click the Chemical Profile link above for detailed information.

Visit Betterchem's Drug Index for…

  • Exclusivity
    Patents and market exclusivity
  • Drug Information
    Prescribing and other information
  • DMFs
    Type 2 drug master files
  • Databases
    Free access to database search
  • 21 CFR
    FDA regulations for this drug
  • Federal Register
    FR search results for this drug
  • Drug Recalls
    For Rx's using this API

  FDA Approval Activities for this Drug…

Singulair (Montelukast Sodium) Granules, 4 mg, Merck Research NDA 21-409/S3 12/31/02 1/23/03 4/9/03 Singulair (Montelukast Sodium) Granules, Merck Research NDA 21-409 7/26/02 8/6/02 7/30/02 Singulair (Montelukast Sodium) Tablets & Chewable Tablets & Granules, Merck Research NDA 20-829/S23 & 20-830/S26 & 21-409/S5 10/2/03 10/9/03 10/10/03 Singulair (Montelukast Sodium) Tablets & Chewable Tablets & Granules, 10 mg, 4 & 5 mg & 4 mg, Merck Research NDA 20-829/S17 & 20-830/S20 & 21-409/S3 12/31/02 1/23/03 4/7/03 Singulair (montelukast sodium) Chewable Tablets, Merck & Co., NDA 20-829/S12 08/02/01 08/02/01 Singulair (Montelukast Sodium) Tablets, Merck Research NDA 20-829 & 20-830 2/20/98 9/10/98 12/8/98 5/24/01 Singulair (Montelukast Sodium) Tablets, 10 mg, Merck Research NDA 20-829/S001 2/12/99 7/5/01 Singulair (Montelukast Sodium) Chewable Tablets, 5 mg, Merck Research NDA 20-830/S001 2/12/99 7/5/01 Singulair (Montelukast Sodium) Chewable Tablets, 4 mg, Merck NDA 20-830/S-8 3/3/00 9/7/01 Singulair (montelukast sodium) Chewable Tablets, Merck & Co. NDA 20-830/S-011 11/23/01 11/25/02 04/24/03 Singulair Indication: prophylaxis for asthma in children 2-5 years of age. Singulair (Montelukast Sodium) Tablets & Chewable Tablets, Merck Research Singulair (Montelukast Sodium) Tablets & Chewable Tablets & Oral Granules, Merck Research Laboratories | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Inc., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Inc., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Inc., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck and Co., New or Modified Indication | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., New or Modified Indication | Singulair (montelukast sodium) Oral Granules, Merck and Co., New or Modified Indication | Singulair (montelukast sodium) Oral Granules, Merck and Co., Efficacy Supplement w/Clinical Data | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., Efficacy Supplement w/Clinical Data | Singulair (montelukast sodium) Tablets, Merck and Co., Efficacy Supplement w/Clinical Data | Singulair (montelukast sodium) Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck and Co., Labeling Revision

Visit Betterchem's Drug Index for FDA's latest approval information.


 

Find other drugs…

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health Topics | News Feed for each API | USActives.com | Pharma Job Search | Pharma Company News

© 2011 FindingHealthOnline™